City of Hope Research Featuring the Successful Treatment of the Oldest Patient to Achieve Remission for Leukemia and HIV Published in The New England Journal of Medicine (NEJM)

The case demonstrates that older adults with blood cancers who receive reduced intensity chemotherapy before a stem cell transplant with donor cells that are resistant to HIV may be cured of HIV infection City of Hope’s expertise treating older blood cancer patients with reduced intensity chemotherapy and HIV patients with cancer helped the patient achieve … [Read more…]

Abra Health Group Expands Reach In New Jersey with Grand Opening of New Dental and Pediatric Primary Care Offices in Newark

NEWARK, N.J.–(BUSINESS WIRE)–#NJ–Abra Health Group, a leading dental support and medical support organization, proudly announces the grand opening of its newest offices in Newark, NJ. Abra Dental, the dental division of Abra Health Group, and Abra Health, its pediatric primary care division, are now open at 223 Bloomfield Ave, Newark, NJ. Strategically positioned near Branch … [Read more…]

Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28

CINCINNATI–(BUSINESS WIRE)–Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2023, on Tuesday, February 27, 2024, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 28, 2024, to … [Read more…]

Senior Whole Health by Molina Healthcare Invests $500,000 in Place-Based Supports to Reduce Health Disparities for Seniors in Massachusetts Affordable Housing Sites

BOSTON–(BUSINESS WIRE)–Senior Whole Health by Molina Healthcare (“Senior Whole Health”) in collaboration with The MolinaCares Accord (“MolinaCares”) is announcing a $500,000 investment in organizations providing place-based supports (PBS) for residents of senior affordable housing sites. The resources will enhance care and wellness for facility residents across greater Boston. According to the most recent Elder Index … [Read more…]

HCSG Reports Q4 2023 Results

Exceeds Earnings and Cash Flow Expectations, Revenue In-Line Revenue of $423.8 million; adjusted revenue(1) of $425.0 million, in-line with expectations. Net income and diluted EPS of $22.6 million and $0.31; adjusted net income(1) and adjusted diluted EPS(1) of $14.6 million and $0.20. Adjusted EBITDA(1) of $26.5 million, a 14.2% increase over Q4 2022. Cash flow … [Read more…]

Coreline Soft Showcases Deep Learning AI Imaging Solutions ‘AVIEW’ at ECR 2024

– Exhibition of all AVIEW products that have obtained overseas sales approval, including CE certification VIENNA–(BUSINESS WIRE)–#AI—Coreline Soft, a pioneer in medical artificial intelligence (AI) imaging, unveils cutting-edge AI medical imaging solutions at the ECR 2024 (European Congress of Radiology), establishing a new standard for healthcare across Europe. ECR, the largest radiology conference in Europe, … [Read more…]

Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU

The U.S. Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate to severe atopic dermatitis. Nemolizumab was granted U.S. FDA Priority Review for prurigo nodularis. The European Medicines Agency has also accepted the Marketing Authorization Applications … [Read more…]

Treadwell Announces the Formation and Members of Scientific Advisory Board

TORONTO & SAN FRANCISCO–(BUSINESS WIRE)–Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, … [Read more…]

SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

ATLANTA–(BUSINESS WIRE)–SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for its second fiscal quarter ended December 31, 2023 compared to earnings from continuing operations of $2,277,000 (or $0.32 per fully diluted share) for the second fiscal quarter ended … [Read more…]

Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at The Raymond James & Associates 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5, 2024 at 11:35 a.m. (Eastern Time). To listen to the live … [Read more…]